(Q40385602)

English

Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells

scientific article published on October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

5

object named as

B Mark Evers

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Noriko Yanase

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Kikumi Hata

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Kuniaki Shimo

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Miho Hayashida

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Junichiro Mizuguchi

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

310

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

10-21

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Cytokine therapeutics: lessons from interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Wherefore interferon?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Cytokine research: the interferon paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

How cells respond to interferons

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Mechanisms of Interferon-alpha induced apoptosis in malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Cytotoxic effect of interferon on primary malignant tumour cells. Studies in various malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Participation of Bax-alpha in IFN-alpha-mediated apoptosis in Daudi B lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Molecular regulation of apoptosis: genetic controls on cell death.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Response of hairy cells to IFN-alpha involves induction of apoptosis through autocrine TNF-alpha and protection by adhesion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

How melanoma cells evade trail-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

The role of c-FLIP in modulation of CD95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Mammalian MAP kinase signalling cascades

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

MAP kinases in the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

The JNK signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Differential gene regulation by specific gain-of-function JNK1 proteins expressed in Swiss 3T3 fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Cytochrome c release, mitochondrial membrane depolarization, caspase-3 activation, and Bax-alpha cleavage during IFN-alpha-induced apoptosis in Daudi B lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Prevention of anti-IgM-induced apoptosis accompanying G1 arrest in B lymphoma cells overexpressing dominant-negative mutant form of c-Jun N-terminal kinase 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Isolation and molecular characterization of the 5'-upstream region of the human TRAIL gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Genomic organization and characterization of the promoter for the E2A gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Interferon-beta-induced activation of c-Jun NH2-terminal kinase mediates apoptosis through up-regulation of CD95 in CH31 B lymphoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Actin cleavage by CPP-32/apopain during the development of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Activation of the Jak-Stat Pathway in Cells That Exhibit Selective Sensitivity to the Antiviral Effects of IFN-beta Compared with IFN-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

The kiss of death: promises and failures of death receptors and ligands in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Mitochondria as regulators of apoptosis: doubt no more.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Mechanisms of mitochondrial membrane permeabilization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Signal transduction by the JNK group of MAP kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

JunD mediates survival signaling by the JNK signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Two CD95 (APO-1/Fas) signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Close link between reduction of c-myc expression by interferon and, G0/G1 arrest

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Genomic organization and transcriptional regulation of human Apo2/TRAIL gene.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

AP-1 function and regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Interferon alpha /beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Interferon-alpha promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Combined stimulation with interferon alpha and retinoic acid synergistically inhibits proliferation of the glioblastoma cell line GB12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.06.021

7 January 2021

Identifiers

10.1016/J.YEXCR.2005.06.021

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40385602&oldid=1896722771"